By performing a nested case-control study within the SOS study based on the same patients with incident RA as in our previous study matched 1:5 with controls without incident RA [25], we did not observe any association between leptin, resistin, and visfatin and the risk of future RA. This evidence concerns the gene LEP and rheumatoid arthritis.